As the most densely biodiverse country on earth, Colombia is an ideal base for the development of botanical medicine. In addition to optimal growing conditions, the South American country has a diversified economy—including established agricultural and pharmaceutical industries—macroeconomic stability and favorable growth prospects. LaSanta has been granted licenses by the Colombian government for the legal commercial cultivation, production and export of medicinal cannabis extracts and seeds.
We are developing organic pharmaceutical grade extracts and proprietary formulations, validated through clinical research, for distribution within Colombia and to markets across the globe. With a focussed strategy and premium products, LaSanta is set to become a leading, iconic brand in the global cannabis industry. LaSanta means “the holy”—an ancient term for botanical medicine; our brand evokes the natural healing power of plants.
COLOMBIA IS AN IDEAL BASE FOR THE DEVELOPMENT OF BOTANICAL MEDICINE
LASANTA MEANS “THE HOLY” — AN ANCIENT TERM FOR BOTANICAL MEDICINE; OUR BRAND EVOKES THE NATURAL HEALING POWER OF PLANTS
Santa Marta Gold
square metres of fertile farm land in ideal growing regions north of the capital city of Bogota
Phase I & II:
square metres of operating greenhouse, with a further 18,000 square metres of greenhouse and a GMP lab under development
With industry-leading cultivation and extraction techniques, LaSanta endeavors to bring out the fullest expression of the plant’s genetics.
Cannabis seed bank with over 100 varieties, including heirloom strains from Colombia, such as the iconic Santa Marta Gold and Punto Rojo, and handcrafted strains developed by our passionate team.
Crude extractions as well as unique formulations with other botanicals to address a variety of medical conditions.
LaSanta has received regulatory approval of its first cannabis-infused products.
In-house expertise in organic cultivation—no pesticides, herbicides or synthetic chemicals.
Cold food-grade ethanol extraction to bring out the fullest expression of the plant’s genetics.
Organic medical cannabis, world-class genetic bank, planned EU GMP certification and extensive quality control.
Intent to have lowest cost of production in the world, with inexpensive land, low capital and operating costs.
Exclusive academic affiliations and an R&D team with leaders in the study of cannabinoids; crafting botanical formulations for diverse markets.
Vertical integration, product branding and distribution targeting the sale of high value finished products globally.
Proven business leaders, innovators and entrepreneurs who have built efficient public and private companies from start up to full commercialization in a range of industries.
We are committed to serving the best interest of all shareholders and communicating our financial and operating results in a timely and transparent manner.